Successful Treatment of Invasive Squamous Cell Carcinoma Using Topical Imiquimod
Open Access
- 1 April 2004
- journal article
- case report
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 140 (4) , 404
- https://doi.org/10.1001/archderm.140.4.404
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patientsTransplant International, 2003
- Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% creamJournal of the American Academy of Dermatology, 2002
- Topical immunomodulators—progress towards treating inflammation, infection, and cancerThe Lancet Infectious Diseases, 2001
- Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six casesBritish Journal of Dermatology, 2001
- Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trialJournal of the American Academy of Dermatology, 2001
- Self‐administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosumBritish Journal of Dermatology, 2000
- Co-expression of the Squamous Cell Carcinoma Antigens 1 and 2 in Normal Adult Human Tissues and Squamous Cell CarcinomasJournal of Histochemistry & Cytochemistry, 2000
- Imiquimod, a Topical Immune Response Modifier, Induces Migration of Langerhans Cells11The authors have declared a conflict of interest.Journal of Investigative Dermatology, 2000
- Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% creamJournal of the American Academy of Dermatology, 1999
- Treatment of genital warts with an immune-response modifier (imiquimod)Published by Elsevier ,1998